Supriya Lifescience Limited (BOM:543434)
India flag India · Delayed Price · Currency is INR
952.15
+50.40 (5.59%)
At close: Jun 4, 2026

Supriya Lifescience Statistics

Total Valuation

BOM:543434 has a market cap or net worth of INR 76.29 billion. The enterprise value is 75.56 billion.

Market Cap76.29B
Enterprise Value 75.56B

Important Dates

The last earnings date was Wednesday, May 27, 2026.

Earnings Date May 27, 2026
Ex-Dividend Date Sep 4, 2025

Share Statistics

Current Share Class 80.48M
Shares Outstanding n/a
Shares Change (YoY) +0.01%
Shares Change (QoQ) -0.00%
Owned by Insiders (%) 68.30%
Owned by Institutions (%) 8.83%
Float 25.51M

Valuation Ratios

The trailing PE ratio is 36.48.

PE Ratio 36.48
Forward PE n/a
PS Ratio 9.22
PB Ratio 6.37
P/TBV Ratio 6.38
P/FCF Ratio 227.51
P/OCF Ratio 41.07
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.70, with an EV/FCF ratio of 225.32.

EV / Earnings 36.13
EV / Sales 9.13
EV / EBITDA 25.70
EV / EBIT 28.44
EV / FCF 225.32

Financial Position

The company has a current ratio of 4.40, with a Debt / Equity ratio of 0.00.

Current Ratio 4.40
Quick Ratio 2.46
Debt / Equity 0.00
Debt / EBITDA 0.02
Debt / FCF 0.16
Interest Coverage 140.62

Financial Efficiency

Return on equity (ROE) is 19.06% and return on invested capital (ROIC) is 19.18%.

Return on Equity (ROE) 19.06%
Return on Assets (ROA) 13.45%
Return on Invested Capital (ROIC) 19.18%
Return on Capital Employed (ROCE) 21.49%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 16.08M
Profits Per Employee 4.06M
Employee Count515
Asset Turnover 0.67
Inventory Turnover 1.83

Taxes

In the past 12 months, BOM:543434 has paid 656.59 million in taxes.

Income Tax 656.59M
Effective Tax Rate 23.90%

Stock Price Statistics

The stock price has increased by +33.39% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +33.39%
50-Day Moving Average 693.05
200-Day Moving Average 703.17
Relative Strength Index (RSI) 67.84
Average Volume (20 Days) 46,870

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:543434 had revenue of INR 8.28 billion and earned 2.09 billion in profits. Earnings per share was 25.98.

Revenue8.28B
Gross Profit 5.74B
Operating Income 2.66B
Pretax Income 2.75B
Net Income 2.09B
EBITDA 2.94B
EBIT 2.66B
Earnings Per Share (EPS) 25.98
Full Income Statement

Balance Sheet

The company has 788.67 million in cash and 54.35 million in debt, with a net cash position of 734.32 million.

Cash & Cash Equivalents 788.67M
Total Debt 54.35M
Net Cash 734.32M
Net Cash Per Share n/a
Equity (Book Value) 11.98B
Book Value Per Share 148.77
Working Capital 4.11B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.86 billion and capital expenditures -1.52 billion, giving a free cash flow of 335.34 million.

Operating Cash Flow 1.86B
Capital Expenditures -1.52B
Depreciation & Amortization 284.09M
Net Borrowing 550,000
Free Cash Flow 335.34M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 69.32%, with operating and profit margins of 32.09% and 25.26%.

Gross Margin 69.32%
Operating Margin 32.09%
Pretax Margin 33.19%
Profit Margin 25.26%
EBITDA Margin 35.52%
EBIT Margin 32.09%
FCF Margin 4.05%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.11%.

Dividend Per Share 1.00
Dividend Yield 0.11%
Dividend Growth (YoY) 25.00%
Years of Dividend Growth 2
Payout Ratio 3.85%
Buyback Yield -0.01%
Shareholder Yield 0.09%
Earnings Yield 2.74%
FCF Yield 0.44%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Analyst Forecast

The average price target for BOM:543434 is 940.00, which is -1.28% lower than the current price. The consensus rating is "Buy".

Price Target 940.00
Price Target Difference -1.28%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (3Y) 23.31%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4